| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | — | +5.2% |
| R&D Expense | $535K | — | -68.6% |
| SG&A Expense | $234K | — | -99.5% |
| Operating Income | -$27.7M | — | +37.3% |
| Interest Expense | $4.5M | — | -6.3% |
| Pre-tax Income | -$32.2M | — | +39.4% |
| Income Tax | $52K | — | +116.7% |
| Net Income | -$32.2M | — | +39.3% |
| EPS (Basic) | -$0.16 | — | +50.0% |
| EPS (Diluted) | -$0.16 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.2M | -4.4% | +3.0% |
| Accounts Receivable | $887K | -3.5% | -21.6% |
| Current Assets | $14.3M | -6.0% | -21.7% |
| Total Assets | $34.3M | -3.4% | -24.6% |
| Current Liabilities | $380.7M | +5.4% | +21.8% |
| Total Liabilities | $382.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +82.6% |
| Investing Cash Flow | $283K | — | -81.5% |
| Financing Cash Flow | $2.1M | — | -82.0% |
| +22.4% |
| Stockholders' Equity | -$348.6M | -6.2% | -30.3% |